Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Michael Singer
AddedMar 31, 2024
UpdatedMay 31, 2026
Michael Singer

Michael Singer

Board Member, iVexSol

CrunchbaseLinkedIn

Michael Singer's Career

iVexSol
iVexSol

Lexington, MA, US

Board Member· Board
Pykus Therapeutics
Pykus Therapeutics

Boston, MA, US

Board Member· Board
Cartesian Therapeutics
Cartesian Therapeutics

Gaithersburg, MD, US

Board Member· Board
Anodyne Nanotech
Anodyne Nanotech

Boston, MA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Michael Singer's Career

iVexSol
iVexSol
Series A$39M132010Lexington, MA, US
Board Member· Board

Leadership at iVexSol

Rodney L RietzeRodney L RietzeCo-Founder
Michael GreeneMichael GreeneCo-Founder
Bill MercerBill MercerBoard Member
Pykus Therapeutics
Pykus Therapeutics
Seed$2.6M82016Boston, MA, US
Board Member· Board

Leadership at Pykus Therapeutics

Tomasz StryjewskiTomasz StryjewskiCo-Founder
James (Tony) StefaterJames (Tony) StefaterCo-Founder

Similar to Pykus Therapeutics

Iscience SurgicalIscience SurgicalMenlo Park, CA, USMedical Devicesest. 1999Iscience SurgicalMenlo Park, CA, US · est. 1999

iScience Interventional designs and manufactures innovative biomedical devices for site-specific ocular therapies.

Series C · $22M30
Vortex SurgicalVortex SurgicalChesterfield, MO, USSurgical Disposables, Surgical Instrumentsest. 2016Vortex SurgicalChesterfield, MO, US · est. 2016

Vortex Surgical: Innovating vitreo-retinal surgery with efficient, high-quality disposables and instruments.

Seed · $1.7M16
Mobius TherapeuticsMobius TherapeuticsSt. Louis, MO, USPharmaceuticalsest. 2006Mobius TherapeuticsSt. Louis, MO, US · est. 2006

Mobius Therapeutics: Early-stage venture providing innovative ophthalmic surgery solutions.

Series B · $8.5M31
Perfuse TherapeuticsPerfuse TherapeuticsSan Francisco, CA, USTherapeuticsest. 2018Perfuse TherapeuticsSan Francisco, CA, US · est. 2018

Perfuse Therapeutics: A seed-stage firm innovating retinal disease treatment, starting with glaucoma.

Series A · $9M11
Cartesian Therapeutics
Cartesian Therapeutics
Seed$2M382016Gaithersburg, MD, US
Board Member· Board

Leadership at Cartesian Therapeutics

Murat KalayogluMurat KalayogluCEO

Similar to Cartesian Therapeutics

Cartography BiosciencesCartography BiosciencesFoster City, CA, USCancer Therapiesest. 2020Cartography BiosciencesFoster City, CA, US · est. 2020

Precision therapeutics firm shaping cancer immunotherapies for safe, effective targets.

Seed · $57M55
Ernexa TherapeuticsErnexa TherapeuticsCambridge, MA, USCell Therapiesest. 1984Ernexa TherapeuticsCambridge, MA, US · est. 1984

Eterna Therapeutics: Pioneering cell engineering for cancer and immunologic disease treatment.

Public · $49.1M11
Cellular ApproachesCellular ApproachesLos Angeles, CA, USCell Therapiesest. 2016Cellular ApproachesLos Angeles, CA, US · est. 2016

Cellular Approaches: Innovating in innate immunity biotech for unmet medical needs.

Seed · $2.6M5
Celsius TherapeuticsCelsius TherapeuticsCambridge, MA, USTherapeuticsest. 2018Celsius TherapeuticsCambridge, MA, US · est. 2018

Celsius Therapeutics, a US-based biotech firm, develops drugs for cancer and autoimmune diseases.

Series B · $148M72
Anodyne Nanotech
Anodyne Nanotech
Seed$6.2M182019Boston, MA, US
Board Member· Board

Leadership at Anodyne Nanotech

Konstantinos TzortzakisKonstantinos TzortzakisCo-Founder
Sameer SonkusaleSameer SonkusaleCo-Founder
Jake LombardoJake LombardoCo-Founder
Hojatollah Rezaei NejadHojatollah Rezaei NejadCo-Founder

Similar to Anodyne Nanotech

SingleTimeMicroneedlesSingleTimeMicroneedlesFarmington, CT, USMicroneedle Patches, Vaccinesest. 2022SingleTimeMicroneedlesFarmington, CT, US · est. 2022

Innovative software and microneedle patch company in CT.

Seed · $350k6
Prometheon PharmaPrometheon PharmaGainesville, FL, USDrug Delivery, Patchesest. 2011Prometheon PharmaGainesville, FL, US · est. 2011

Needle-free drug patch developer, delivering large molecules like insulin, boosting patient compliance.

Pre-Seed · $1.1M2
Avro Life ScienceAvro Life ScienceWaterloo, Ontario, CADrug Delivery, Skin Patchesest. 2016Avro Life ScienceWaterloo, Ontario, CA · est. 2016

Innovative skin patch tech for generic drug delivery, with a focus on therapeutics for children and the elderly.

Series A · $4.4M18
VeraDermicsVeraDermicsSan Antonio, TX, USDrug Delivery, Therapeuticsest. 2019VeraDermicsSan Antonio, TX, US · est. 2019

VeraDermics: A dermatology firm offering pain-free, microneedle patch solutions for skin conditions.

Series B · $35.7M11

Michael Singer's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Michael Singer

John ScottJohn ScottCo-Founder · Cartesian LabsDaniel WelchDaniel WelchBoard Member · Ultragenyx PharmaceuticalRobert A. DeAngelisRobert A. DeAngelisCEO · Cartesian Capital GroupTim PatrickTim PatrickBoard Member · Carticept MedicalMichael SchmertzlerMichael SchmertzlerBoard Member · PTC Therapeutics